awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47250599-373E89DC-97D7-4E8A-978B-4F789E868E30
Q47250599-373E89DC-97D7-4E8A-978B-4F789E868E30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47250599-373E89DC-97D7-4E8A-978B-4F789E868E30
Emergence of a Promising Lead Compound in the Treatment of Triple Negative Breast Cancer: An Insight into Conformational Features and Ligand Binding Landscape of c-Src Protein with UM-164.
P2860
Q47250599-373E89DC-97D7-4E8A-978B-4F789E868E30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47250599-373E89DC-97D7-4E8A-978B-4F789E868E30
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2168a611aae03ea2f25b501c240c63446fe7f366
P2860
Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study.